Serious adverse events associated with yellow fever vaccine.

Abstract

Yellow fever vaccine was considered one of the safest vaccines, but in recent years it was found that it could rarely cause invasive and disseminated disease in some otherwise healthy individuals, with high lethality. After extensive studies, although some risk factors have been identified, the real cause of causes of this serious adverse event are largely unknown, but findings point to individual host factors. Meningoencephalitis, once considered to happen only in children less than 6 months of age, has also been identified in older children and adults, but with good prognosis. Efforts are being made to develop a safer yellow fever vaccine, and an inactivated vaccine or a vaccine prepared with the vaccine virus envelope produced in plants are being tested. Even with serious and rare adverse events, yellow fever vaccine is the best way to avoid yellow fever, a disease of high lethality and should be used routinely in endemic areas, and on people from non-endemic areas that could be exposed, according to a careful risk-benefit analysis.

• Authors: Reinaldo de Menezes Martins, Maria da Luz Fernandes Leal, Akira Homma
• Journal: Human vaccines & immunotherapeutics (Hum Vaccin Immunother) Vol. 11 Issue 9 Pg. 2183-7 ( 2015) ISSN: 2164-554X [Electronic] United States
• PMID: 26090855 (Publication Type: Journal Article)

Chemical References

• Yellow Fever Vaccine

Topics

• Adolescent
• Adult
• Aged
• Aged, 80 and over
• Child
• Child, Preschool
• Drug-Related Side Effects and Adverse Reactions (epidemiology, pathology)
• Female
• Humans
• Infant
• Male
• Middle Aged
• Yellow Fever Vaccine (administration & dosage, adverse effects)
• Young Adult